{"title":"PHARMACOGNOSTICAL AND PHARMACEUTICAL ANALYSIS OF SHAWASAHARA DASHEMANI AVALEHA","authors":"K. Soni","doi":"10.20959/WJPR201711-9553","DOIUrl":null,"url":null,"abstract":"Tamaka Shwaasa is basically a disorder of Praanavaha Srootasas while other Srootasas are also vitiated. The parallel disease entity in contemporary medical science to this disorder is Bronchial Asthma. Bronchial Asthma is a chronic inflammatory condition of the lung airways resulting in episodic airflow obstruction. This disease is more predominant in children and aged population. In Charaka Samhita, the group of ten drugs is mentioned for the management of the Shwasa Roga named as Shwasahara Dashemani. Palatability is a main issue in treatment of children so keep it mind the avaleha form is prepared which is very easily palatable in children. Till date no published data is available regarding evaluation the effect of Shwasahara Dashemani Avaleha. Methods: Final product was subjected to Phrmacognostical and physico-chemical analysis such as microscopic study, loss on drying, ash value, pH etc. Results: Phrmacognostical study showed the presence of contents such as; annular vessels of Shati, simple trichome of Tulsi, rossels crystal of Jivanti etc. Preliminary physico-chemical analysis showed that the loss on drying value was found to be 25.66%, pH 6.5, Ash value-o.88%, Water soluble extract 76.01% etc. High Performance Thin Layer Chromatography (HPTLC) showed 6 and 3 spots at 254nm and 366nm respectively. Conclusion: The present work was carried out to standardize the finished product Shwasahara dashemani Churna in terms of its identity, World Journal of Pharmaceutical Research SJIF Impact Factor 7.523 Volume 6, Issue 11, 740-747. Research Article ISSN 2277– 7105 Article Received on 27 July 2017, Revised on 16 August 2017, Accepted on 05 Sept. 2017 DOI: 10.20959/wjpr201711-9553 *Corresponding Author Dr. Kuldeep Kumar Soni PG Scholar, 2 nd yr, Department of Kaumarbhritya. I.P.G.T. and R.A, GAU.","PeriodicalId":23796,"journal":{"name":"World journal of pharmaceutical research","volume":"54 1","pages":"740-747"},"PeriodicalIF":0.0000,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of pharmaceutical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20959/WJPR201711-9553","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Tamaka Shwaasa is basically a disorder of Praanavaha Srootasas while other Srootasas are also vitiated. The parallel disease entity in contemporary medical science to this disorder is Bronchial Asthma. Bronchial Asthma is a chronic inflammatory condition of the lung airways resulting in episodic airflow obstruction. This disease is more predominant in children and aged population. In Charaka Samhita, the group of ten drugs is mentioned for the management of the Shwasa Roga named as Shwasahara Dashemani. Palatability is a main issue in treatment of children so keep it mind the avaleha form is prepared which is very easily palatable in children. Till date no published data is available regarding evaluation the effect of Shwasahara Dashemani Avaleha. Methods: Final product was subjected to Phrmacognostical and physico-chemical analysis such as microscopic study, loss on drying, ash value, pH etc. Results: Phrmacognostical study showed the presence of contents such as; annular vessels of Shati, simple trichome of Tulsi, rossels crystal of Jivanti etc. Preliminary physico-chemical analysis showed that the loss on drying value was found to be 25.66%, pH 6.5, Ash value-o.88%, Water soluble extract 76.01% etc. High Performance Thin Layer Chromatography (HPTLC) showed 6 and 3 spots at 254nm and 366nm respectively. Conclusion: The present work was carried out to standardize the finished product Shwasahara dashemani Churna in terms of its identity, World Journal of Pharmaceutical Research SJIF Impact Factor 7.523 Volume 6, Issue 11, 740-747. Research Article ISSN 2277– 7105 Article Received on 27 July 2017, Revised on 16 August 2017, Accepted on 05 Sept. 2017 DOI: 10.20959/wjpr201711-9553 *Corresponding Author Dr. Kuldeep Kumar Soni PG Scholar, 2 nd yr, Department of Kaumarbhritya. I.P.G.T. and R.A, GAU.